Who owns IRONWOOD PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Ironwood Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Ironwood Pharmaceuticals stock

Who bought or sold IRONWOOD PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Capstone Investment Advisors 52M $52M 8% Mar 2024
 View chart
Tenor Capital Management 37M $37B 9% Mar 2024
 View chart
Braidwell 20M $20M -47% Mar 2024
 View chart
DeepCurrents Investment Group 19M $18M 100% Mar 2024
 View chart
Balyasny Asset Management 18M $18M -60% Mar 2024
 View chart
Jpmorgan Chase & Co 11M $11M 1239% Mar 2024
 View chart
Leucadia National Corporation 8.9M $8.9M 100% Mar 2024
 View chart
Bank Of Montreal 8.5M $8.4M 100% Mar 2024
 View chart
DLD Asset Management 8.2M $8.7M 9% Dec 2023
 View chart
Verition Fund Management 5.8M $5.8M 100% Mar 2024
 View chart
Calamos Advisors 5.0M $5.0M 0% Mar 2024
 View chart
Citigroup 2.4M $2.3M 833% Mar 2024
 View chart
Wells Fargo & Company 2.0M $2.0M 100% Mar 2024
 View chart
Groupama Asset Managment 1.0M $920k 100% Mar 2024
 View chart
Virtus Investment Advisers 42k $42k 0% Mar 2024
 View chart
Arkadios Wealth Advisors 11k $11k 0% Mar 2024
 View chart
Northwestern Mutual Wealth Management Company 6.0k $6.0k 0% Mar 2024
 View chart

Who sold out of Ironwood Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Shenkman Capital Management Dec 2023 17M $19B
Wellesley Investment Advisors Sep 2023 3.7M $3.6B
Boothbay Fund Management Sep 2023 3.1M $3.0M
Jane Street Dec 2023 3.0M $3.1M
Worth Venture Partners Dec 2023 1.6M $1.7M
Bank of America Corporation Dec 2023 800k $834k
Bank of New York Mellon Dec 2023 200k $208k
Multi-Financial Securities Sep 2023 21k $21k
Financial Network Investment Corporation Sep 2023 17k $17k